{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:27:50Z","timestamp":1789644470239,"version":"4.0.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012706","name":"University of Warmia and Mazury in Olsztyn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.seminoncol.2025.152425","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:16:06Z","timestamp":1761311766000},"page":"152425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The nervous system in prostate cancer: A basic science and clinical perspective"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-9611","authenticated-orcid":false,"given":"Dawid","family":"Sigorski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kasprzyk-Pawelec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Sosnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142 M.","family":"Hryciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Sejda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Gulczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kitlinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"Nawrocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"I\u017cycka-\u015awieszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2025.152425_bib0001","unstructured":"Prostate Cancer \u2014 Cancer Stat Facts, (n.d.). https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html (Accessed March 27, 2025)."},{"key":"10.1016\/j.seminoncol.2025.152425_bib0002","unstructured":"European Association of Urology - Uroweb, (n.d.). https:\/\/uroweb.org\/ (Accessed March 4, 2025)."},{"key":"10.1016\/j.seminoncol.2025.152425_bib0003","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","article-title":"Autonomic nerve development contributes to prostate cancer progression","volume":"341","author":"Magnon","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0004","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-08-1164","article-title":"Cancer-related axonogenesis and neurogenesis in prostate Cancer","volume":"14","author":"Ayala","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4103\/aja.aja_31_18","article-title":"Risk of prostate cancer in men with spinal cord injury: a systematic review and meta-analysis","volume":"20","author":"Barbonetti","year":"2018","journal-title":"Asian J Androl"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0006","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/01952307.1994.11735926","article-title":"Low prevalence of prostatic cancer among myelopathy patients","volume":"17","author":"Frisbie","year":"1994","journal-title":"J Am Paraplegia Soc"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0007","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1600-0447.1992.tb10325.x","article-title":"Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients","volume":"85","author":"Mortensen","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0008","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.comppsych.2014.05.007","article-title":"Risk of prostate cancer in patients with schizophrenia","volume":"55","author":"Raviv","year":"2014","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0009","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-031521-023248","article-title":"Neuroepithelial interactions in cancer","author":"Ayala","year":"2023","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-024-02219-0","article-title":"Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0011","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049729","article-title":"Understanding and modeling nerve-cancer interactions","volume":"16","author":"Le","year":"2023","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-031-32429-1_11","article-title":"Tools and model systems to study nerve-cancer interactions","author":"Wang","year":"2023","journal-title":"Cancer Neurosci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0013","first-page":"1","article-title":"Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche","volume":"9","author":"Chen","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0014","first-page":"273","article-title":"Neuroendocrine differentiation of prostate cancer: a review","volume":"2","author":"Parimi","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0015","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.3389\/fonc.2021.710899","article-title":"Investigation of neural microenvironment in prostate cancer in context of neural density, perineural invasion, and neuroendocrine profile of tumors","volume":"11","author":"Sigorski","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000505437","article-title":"Complexity of neural component of tumor microenvironment in prostate cancer","volume":"87","author":"Sejda","year":"2020","journal-title":"Pathobiology"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110240","article-title":"Activation of TGF-\u03b2 - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK","volume":"91","author":"Natani","year":"2022","journal-title":"Cell Signal"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0018","first-page":"1868","article-title":"AMPK\/SIRT1 signaling through p38MAPK mediates interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells","author":"Natani","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0019","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1158\/1078-0432.CCR-22-3736","article-title":"Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen receptor pathway inhibitors","volume":"29","author":"Menssouri","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0020","article-title":"Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer","author":"Huang","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0021","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/cas.14935","article-title":"Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13","volume":"112","author":"Okasho","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0022","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.1002\/cpz1.742","article-title":"Preclinical models of neuroendocrine prostate cancer","volume":"3","author":"Cacciatore","year":"2023","journal-title":"Curr Protoc"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cells13161396","article-title":"Impact of neuroendocrine differentiation (NED) on enzalutamide and abiraterone efficacy in metastatic castration-resistant prostate cancer (mCRPC): a retrospective analysis","volume":"13","author":"Farinea","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0024","article-title":"Enzalutamide-induced upregulation of PCAT6 promotes prostate cancer neuroendocrine differentiation by regulating miR-326\/HNRNPA2B1 axis","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0025","article-title":"TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0026","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.molonc.2015.02.010","article-title":"Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells \u2192 androgen receptor (AR) \u2192 miRNA32 signals","volume":"9","author":"Dang","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0027","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/pros.23221","article-title":"Neuronal trans-differentiation in prostate cancer cells","volume":"76","author":"Farach","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0028","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41420-021-00752-1","article-title":"Sympathetic signaling facilitates progression of neuroendocrine prostate cancer","volume":"7","author":"Dwivedi","year":"2021","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0029","article-title":"Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215610","article-title":"Emerging experimental models for assessing perineural invasion in human cancers","volume":"535","author":"Jiang","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12092651","article-title":"Cellular and molecular progression of prostate cancer: models for basic and preclinical research","volume":"12","author":"Saranyutanon","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S0041-87812002000600008","article-title":"Reviews prostate innervation and local anesthesia in prostate procedures","volume":"57","author":"Oliveira Rodrigues","year":"2002","journal-title":"Rev Hosp Cl\u00edn Fac Med S Paulo"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-020-00778-0","article-title":"The distribution pattern of periprostatic neurovascular bundles examined with successive celloidin slices","volume":"21","author":"Li","year":"2021","journal-title":"BMC Urol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0034","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/pros.24667","article-title":"Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy","volume":"84","author":"Alanazi","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3346\/jkms.2010.25.4.608","article-title":"Neuroanatomical study of periprostatic nerve distributions using Human cadaver prostate","volume":"25","author":"Sung","year":"2010","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0036","doi-asserted-by":"crossref","first-page":"139","DOI":"10.12954\/PI.13020","article-title":"A comprehensive review of neuroanatomy of the prostate","volume":"1","author":"Park","year":"2013","journal-title":"Prostate Int"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0037","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4149\/neo_2023_231116N593","article-title":"Innervation density and types of nerves in prostate cancer","volume":"70","author":"Blasko","year":"2023","journal-title":"Neoplasma"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0038","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jocn.2019.01.052","article-title":"Prostatic nerve subtypes independently predict biochemical recurrence in prostate cancer","volume":"63","author":"Reeves","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/pros.24667","article-title":"Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy","volume":"84","author":"Alanazi","year":"2024","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4161\/org.24843","article-title":"Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression","volume":"9","author":"White","year":"2013","journal-title":"Organogenesis"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102335","article-title":"Remarks on selected morphological aspects of cancer neuroscience: a microscopic photo review","volume":"12","author":"I\u017cycka-\u015awieszewska","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0042","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4149\/neo_2023_231116N593","article-title":"Innervation density and types of nerves in prostate cancer","volume":"70","author":"Blasko","year":"2023","journal-title":"Neoplasma"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0043","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.5489\/cuaj.2619","article-title":"Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?","volume":"9","author":"Reeves","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0044","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","article-title":"Progenitors from the central nervous system drive neurogenesis in cancer","volume":"569","author":"Mauffrey","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0045","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1158\/0008-5472.CAN-05-1847","article-title":"Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma","volume":"66","author":"Ayala","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0046","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1158\/2159-8290.CD-23-1495","article-title":"Next directions in the neuroscience of cancers arising outside the CNS","volume":"14","author":"Amit","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0047","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.3390\/cancers14194817","article-title":"Nerve density and neuronal biomarkers in cancer","volume":"14","author":"Ali","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0048","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/cncr.24396","article-title":"Perineural invasion in cancer: a review of the literature","volume":"115","author":"Liebig","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0049","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2014.02.011","article-title":"Biological correlates of prostate cancer perineural invasion diameter","volume":"45","author":"Olar","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0050","doi-asserted-by":"crossref","unstructured":"Batsakis JG, Nerves and neurotropic carcinomas, Ann Otol Rhinol Laryngol 94 (n.d.) 426-7. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4026129 (Accessed May 17, 2019).","DOI":"10.1177\/000348948509400420"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0051","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00428-021-03039-z","article-title":"Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies","volume":"478","author":"Egevad","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0052","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1158\/1078-0432.CCR-21-4543","article-title":"Spatial and transcriptomic analysis of perineural invasion in oral cancer","volume":"28","author":"Schmitd","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0053","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2021.08.008","article-title":"Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection","volume":"117","author":"Wu","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0054","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-022-03326-3","article-title":"Detection of perineural invasion in prostate needle biopsies with deep neural networks","volume":"481","author":"Kartasalo","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11517-022-02711-z","article-title":"Expectation-maximization algorithm leads to domain adaptation for a perineural invasion and nerve extraction task in whole slide digital pathology images","volume":"61","author":"Li","year":"2023","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0056","article-title":"Multiparametric MRI and machine learning based radiomic models for preoperative prediction of multiple biological characteristics in prostate cancer","volume":"12","author":"Fan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0057","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax6040","article-title":"Sight and switch off: nerve density visualization for interventions targeting nerves in prostate cancer","volume":"6","author":"You","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0058","first-page":"1","article-title":"3D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review","volume":"17","author":"Coles-Black","year":"2023","journal-title":"J Robot Surg"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0059","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.acuro.2021.09.005","article-title":"The association between perineural invasion in mpMRI-targeted and\/or systematic prostate biopsy and adverse pathological outcomes in robot-assisted radical prostatectomy","volume":"46","author":"Karsiyakali","year":"2022","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0060","article-title":"Preoperative platelet count correlates with postoperative perineural invasion on specimen in patients treated with radical prostatectomy","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0061","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07357907.2021.2019263","article-title":"International Society of Urological Pathology (ISUP)-grade grouping in prostatic adenocarcinoma and its prognostic implications","volume":"40","author":"Hashmi","year":"2021","journal-title":"Cancer Investig"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0062","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/1055-9965.EPI-16-0237","article-title":"Perineural invasion and risk of lethal prostate cancer","volume":"26","author":"Zareba","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.02.008","article-title":"Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy","volume":"36","author":"Peng","year":"2018","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0064","doi-asserted-by":"crossref","DOI":"10.1111\/his.14934","article-title":"Biopsy prostate cancer perineural invasion and tumour load are associated with positive posterolateral margins at radical prostatectomy: implications for planning of nerve-sparing surgery","author":"van der Slot","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/JU.0000000000003461","article-title":"Identifying men who can remain on active surveillance despite biopsy reclassification to grade group 2 prostate cancer","volume":"210","author":"Baraban","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0066","article-title":"Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance","author":"Ding","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0067","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4065\/72.9.823","article-title":"Magnetic resonance imaging in cancer-related lumbosacral plexopathy","volume":"72","author":"Taylor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0068","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3171\/2014.12.JNS141339","article-title":"Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report","volume":"122","author":"Capek","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0069","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.20597","article-title":"Case of the month neoplastic lumbosacral radiculoplexopathy in prostate cancer by direct perineural spread: an unusual entity","volume":"34","author":"Ladha","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00701-017-3423-6","article-title":"Mathematical model of perineural tumor spread: a pilot study","volume":"160","author":"Jacobs","year":"2018","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0071","first-page":"1","article-title":"Prostate cancer","volume":"17","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0072","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11914-018-0489-x","article-title":"Crosstalk between sensory nerves and cancer in bone","volume":"16","author":"Yoneda","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0073","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4615-3398-6_7","article-title":"Hemodynamics of prostate bone metastases","volume":"324","author":"Resnick","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0074","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/cncr.11522","article-title":"Brain metastasis from prostate carcinoma","volume":"98","author":"Tremont-Lukats","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0075","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00415-016-8090-7","article-title":"Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes","volume":"263","author":"Storstein","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0076","first-page":"1","article-title":"Cancer cell\u2019s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction","volume":"10","author":"Yin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0077","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.14107","article-title":"Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: ten year data from the TROG 03.04 RADAR trial","volume":"77","author":"Delahunt","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0078","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.7314\/APJCP.2013.14.5.3289","article-title":"Retrospective study of predictors of bone metastasis in prostate cancer cases","volume":"14","author":"Ho","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0079","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/pros.23067","article-title":"Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer","volume":"75","author":"Ciftci","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100387","article-title":"Sensory nerves: a driver of the vicious cycle in bone metastasis?","volume":"30","author":"Yoneda","year":"2021","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0081","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","article-title":"Nerve dependence: from regeneration to cancer","volume":"31","author":"Boilly","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0082","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0083","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.3390\/cancers14174065","article-title":"The role of perineural invasion in prostate cancer and its prognostic significance","volume":"14","author":"Niu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-022-00398-w","article-title":"Molecular mechanisms and clinical applications of exosomes in prostate cancer","volume":"10","author":"Cui","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040857","article-title":"Tunneling nanotubes and tumor microtubes in cancer","volume":"12","author":"Roehlecke","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-44346-5","article-title":"Stress-induced tunneling nanotubes support treatment adaptation in prostate cancer","volume":"9","author":"Kretschmer","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0087","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1016\/j.ajpath.2014.08.009","article-title":"ProNGF correlates with gleason score and is a potential driver of nerve infiltration in prostate cancer","volume":"184","author":"Pundavela","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0088","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-017-0024-3","article-title":"Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach","volume":"4","author":"Di Donato","year":"2018","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0089","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-023-01008-4","article-title":"The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue","volume":"13","author":"Di Donato","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/eje.0.1470407","article-title":"Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145","volume":"147","author":"Sigala","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0091","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0092","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.18632\/oncotarget.3040","article-title":"DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance","volume":"6","author":"Huber","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0093","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.prp.2017.02.007","article-title":"Expression of NGF, GDNF and MMP-9 in prostate carcinoma","volume":"213","author":"Baspinar","year":"2017","journal-title":"Pathol Res Pr"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0094","doi-asserted-by":"crossref","first-page":"E2008","DOI":"10.1073\/pnas.1402944111","article-title":"GFR\u03b11 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling","volume":"111","author":"He","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0095","doi-asserted-by":"crossref","first-page":"S1186","DOI":"10.1016\/j.annonc.2022.07.1888","article-title":"1402P Initial results of a cohort of advanced prostate cancer patients in a phase ia study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody","volume":"33","author":"Medic","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0096","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1096\/fj.201802159RRR","article-title":"Activation of BDNF\/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance","volume":"34","author":"Li","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0097","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1096\/fba.2021-00085","article-title":"ELISA-based quantification of neurotrophic growth factors in urine from prostate cancer patients","volume":"3","author":"March","year":"2021","journal-title":"FASEB Bioadv"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0098","first-page":"1","article-title":"Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread","volume":"2022","author":"Sigorski","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0099","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-024-10237-z","article-title":"Neuropeptide Y in cancer-biological functions and potential clinical implications","volume":"44","author":"Sigorski","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/pros.20323","article-title":"Bystin in perineural invasion of prostate cancer","volume":"66","author":"Ayala","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0101","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/pros.20294","article-title":"Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer,","volume":"65","author":"Dai","year":"2005","journal-title":"The Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0102","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1158\/0008-5472.CAN-04-0838","article-title":"Growth and survival mechanisms associated with perineural invasion in prostate cancer","volume":"64","author":"Ayala","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0103","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1158\/1078-0432.CCR-12-3669","article-title":"Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer","volume":"19","author":"Ding","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0104","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.07.019","article-title":"Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density","volume":"38","author":"H\u00e4nze","year":"2020","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.semcancer.2022.02.017","article-title":"Chemokines and cytokines: axis and allies in prostate cancer pathogenesis","volume":"86","author":"Mughees","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21124449","article-title":"Cytokines and chemokines as mediators of prostate cancer metastasis","volume":"21","author":"Adekoya","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0107","first-page":"1544","article-title":"CX3CL1\/fractalkine enhances prostate cancer spinal metastasis by activating the src\/FAK pathway","volume":"53","author":"Liu","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0108","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","article-title":"CX3CR1-Fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of Human prostate cancer cells","volume":"64","author":"Shulby","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0109","doi-asserted-by":"crossref","unstructured":"Korbecki J, Sim\u00ed Nska D, Kojder K, et al. Molecular sciences fractalkine\/CX3CL1 in neoplastic processes, (n.d.). https:\/\/doi.org\/10.3390\/ijms21103723.","DOI":"10.3390\/ijms21103723"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0110","first-page":"321","article-title":"Adrenergic nerves activate an angio-metabolic switch in prostate cancer","volume":"358","author":"Zahalka","year":"2017","journal-title":"Science (1979)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0111","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pros.23771","article-title":"Vasa nervorum angiogenesis in prostate cancer with perineural invasion","volume":"79","author":"Ghinea","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0112","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11934-001-0045-5","article-title":"Management of erectile dysfunction following radical prostatectomy","volume":"2","author":"Zippe","year":"2001","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0113","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/prm2.12121","article-title":"Prostatectomy postoperative urinary incontinence: from origin to treatment","volume":"12","author":"Jing","year":"2023","journal-title":"Precis Med Sci"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0114","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bju.14062","article-title":"Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review","volume":"121","author":"Ilic","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-022-02010-9","article-title":"Variability of \u03b1\/\u03b2 ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy","volume":"17","author":"Cui","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0116","first-page":"71","article-title":"The role of biologically effective dose (BED) in clinical oncology","volume":"13","author":"Jones","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0117","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0118","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(16)30070-5","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Incrocci","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0119","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00066-016-0971-2","article-title":"SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: toxicity and quality of life assessment","volume":"192","author":"Rucinska","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0121","first-page":"204","article-title":"Peripheral neuropathy caused by Paclitaxel and Docetaxel: an evaluation and comparison of symptoms","volume":"4","author":"Tofthagen*","year":"2013","journal-title":"J Adv Pr Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102251","article-title":"Central nervous system toxicity in prostate cancer patients treated with androgen receptor signaling inhibitors: a systematic review, Meta-analysis, and network meta-analysis","volume":"23","author":"Matsukawa","year":"2025","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0123","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41391-023-00785-w","article-title":"Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis","volume":"27","author":"Hinojosa-Gonzalez","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0124","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5213\/inj.1920edi.005","article-title":"Treatment of prostate disease and cognitive problems","volume":"23","author":"Cho","year":"2019","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0125","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&dagger","volume":"31","author":"Parker","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0126","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/pros.20958","article-title":"Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo","volume":"69","author":"Karsenty","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0127","unstructured":"Botox-induced prostatic involution - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/9721068\/ (Accessed March 13, 2024)."},{"key":"10.1016\/j.seminoncol.2025.152425_bib0128","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1158\/1078-0432.CCR-05-1222","article-title":"Botulinum toxin potentiates cancer radiotherapy and chemotherapy","volume":"12","author":"Ansiaux","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pros.23454","article-title":"Influence of the neural microenvironment on prostate cancer","volume":"78","author":"Coarfa","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0130","unstructured":"Prostatic carcinoma shrunk after intraprostatic injection of botulinum toxin - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/21910106\/ (Accessed March 13, 2024)."},{"key":"10.1016\/j.seminoncol.2025.152425_bib0131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/luts.12003","article-title":"OnobotulinumtoxinA has No effects on growth of LNCaP and PC3 Human prostate cancer cells","volume":"5","author":"Cheng","year":"2013","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0132","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/aja.aja_55_18","article-title":"Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling","volume":"20","author":"Yin","year":"2018","journal-title":"Asian J Androl"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.06.002","article-title":"Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer","volume":"38","author":"Kwon","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0134","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00375","article-title":"\u03b2-adrenergic receptor signaling in prostate cancer","volume":"4","author":"Braadland","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5603\/OCP.2022.0016","article-title":"Benefits of \u03b2-blockers in cancer treatment","volume":"19","author":"Arif","year":"2023","journal-title":"Oncol Clin Pract"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0136","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2125.2011.03980.x","article-title":"Does \u03b2-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study","volume":"72","author":"Shah","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.03.024","article-title":"Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population","volume":"38","author":"Zahalka","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0138","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5603\/OCP.2022.0016","article-title":"Benefits of \u03b2-blockers in cancer treatment","volume":"19","author":"Arif","year":"2023","journal-title":"Oncol Clin Pract"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0139","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00262-010-0934-x","article-title":"Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis","volume":"60","author":"Warrington","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0140","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.1158\/0008-5472.CAN-05-0826","article-title":"A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone","volume":"65","author":"Halvorson","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0141","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.pain.2011.07.020","article-title":"Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain","volume":"152","author":"Jimenez-Andrade","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0142","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113691","article-title":"Perineural invasion-associated biomarkers for tumor development","volume":"155","author":"Liu","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0143","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/andr.12578","article-title":"The clinical significance of perineural invasion in patients with de novo metastatic prostate cancer","volume":"7","author":"Zhao","year":"2019","journal-title":"Andrology"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0144","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcp\/aqac142","article-title":"Clinical significance of perineural invasion by prostate cancer detected on needle core biopsy: unilateral vs bilateral involvement","volume":"159","author":"Teramoto","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0145","article-title":"Are diabetic patients at increased risk for biochemical recurrence after radical prostatectomy?","volume":"14","author":"Alouane","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0146","first-page":"59","article-title":"Incidence and predicting factors of histopathological features at robot-assisted radical prostatectomy in the mpMRI era: results of a single tertiary referral center","author":"Di Mauro","year":"2023","journal-title":"Med (B Aires)"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0147","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00345-022-04158-1","article-title":"Perineural invasion as predictor of biochemical recurrence in prostate cancer following open radical prostatectomy: a single-center experience","volume":"40","author":"Stankovic","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0148","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4081\/aiua.2020.4.330","article-title":"Perineural invasion in prostate needle biopsy: prognostic value on radical prostatectomy and active surveillance","volume":"92","author":"Ramos","year":"2020","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0149","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.humpath.2020.07.005","article-title":"Quantification of perineural invasion focus after radical prostatectomy could improve predictive power of recurrence","volume":"104","author":"Wu","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-020-01977-7","article-title":"Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy","volume":"18","author":"Lian","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.seminoncol.2025.152425_bib0151","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.adro.2018.09.006","article-title":"The perineural Invasion paradox: is perineural invasion an independent prognostic indicator of biochemical recurrence risk in patients with pT2N0R0 prostate cancer? A multi-institutional study","volume":"4","author":"Kraus","year":"2018","journal-title":"Adv Radiat Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:50:49Z","timestamp":1773013849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":151,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0093775425001174"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152425","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nervous system in prostate cancer: A basic science and clinical perspective","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152425"}}